089140 — NexturnBioScience Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩36bn
- KR₩81bn
- KR₩32bn
Annual cashflow statement for NexturnBioScience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3,430 | -3,997 | -4,448 | 9,681 | -13,005 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1,902 | 3,489 | 2,161 | -7,219 | 13,120 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1,249 | 3,121 | -712 | -6,435 | -3,271 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 236 | 3,664 | -1,191 | -1,971 | -1,143 |
| Capital Expenditures | -57.2 | -487 | -282 | -1,082 | -730 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 73.8 | -72,764 | -56,229 | -16,335 | -8,890 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 16.6 | -73,251 | -56,511 | -17,417 | -9,621 |
| Financing Cash Flow Items | — | -10.1 | -311 | 5,275 | -46.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,095 | 37,457 | 47,937 | 22,492 | 7,528 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,534 | -32,068 | -9,989 | 3,093 | -3,134 |